550 related articles for article (PubMed ID: 17699277)
1. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
[TBL] [Abstract][Full Text] [Related]
2. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic approach in autosomal dominant polycystic kidney disease.
Pei Y
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
[TBL] [Abstract][Full Text] [Related]
5. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
6. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
Med Clin (Barc); 1998 Apr; 110(13):481-7. PubMed ID: 9611728
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and prognosis of autosomal dominant polycystic kidney disease.
Parfrey PS; Bear JC; Morgan J; Cramer BC; McManamon PJ; Gault MH; Churchill DN; Singh M; Hewitt R; Somlo S
N Engl J Med; 1990 Oct; 323(16):1085-90. PubMed ID: 2215575
[TBL] [Abstract][Full Text] [Related]
8. [Genetic analysis (PKD2) of autosomal dominant polycystic kidney disease].
Gómez PF; Moro EC; García-Cosmes P; Sarmiento RG; Romo JM
Nefrologia; 2009; 29(6):562-8. PubMed ID: 19936001
[TBL] [Abstract][Full Text] [Related]
9. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
Hoefele J; Mayer K; Scholz M; Klein HG
Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
[TBL] [Abstract][Full Text] [Related]
10. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
[TBL] [Abstract][Full Text] [Related]
11. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
[TBL] [Abstract][Full Text] [Related]
12. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
[TBL] [Abstract][Full Text] [Related]
13. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
15. DNA diagnosis and clinical manifestations of autosomal dominant polycystic kidney disease.
Merta M; Stekrová J; Zidovská J; Vorsilková M; Walterová J; Kapras J; Alánová M; Rasková D; Gaillyová R; Archmanová E; Rysavá R
Folia Biol (Praha); 1997; 43(5):201-4. PubMed ID: 9595261
[TBL] [Abstract][Full Text] [Related]
16. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
17. [Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
Torra R; Badenas C; Pérez-Oller L; San Millán JL; Tellería D; Estivill X; Darnell A
Nefrologia; 2000; 20(1):39-46. PubMed ID: 10822721
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
[TBL] [Abstract][Full Text] [Related]
19. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2).
Stypmann J; Engelen MA; Orwat S; Bilbilis K; Rothenburger M; Eckardt L; Haverkamp W; Horst J; Dworniczak B; Pennekamp P
Int J Cardiol; 2007 Aug; 120(2):158-66. PubMed ID: 17182135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
